US 11351161
Use of CDK9 inhibitors to reduce cartilage degradation
granted A61KA61K31/453A61K31/713
Quick answer
US patent 11351161 (Use of CDK9 inhibitors to reduce cartilage degradation) held by The Regents of the University of California expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/453, A61K31/713, A61K9/0019, A61P